SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

24 8,539 5,000 6,000 7,000 8,000 9,000 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Zohydro Total TRx Source: Symphony Health Integrated DataVerse (IDV) Zohydro ® ER with BeadTek ® TRx Trends Monthly TRx Steady increase in TRx • Reduction of sales force in July 2016 • Stockout of 20mg dosage strength, which represented the largest volume mg strength in 2016, announced in May 2017 • Reduction of sales force in January 2018 • Return to market of 20mg dosage strength announced March 2018 • On November 21, 2018, the Company announced that the 20mg dosage strength will be on back order until at least the second quarter of 2019. Refer to 8 - K filed on 11/21 A B C A 42.4% growth since April 2015 D C B E D E